Hepatitis Monthly

Published by: Kowsar

Ursodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysis

Yang Zhang 1 , 2 , Linlin Lu 3 , 4 , David W Victor 5 , Yongning Xin 1 , 2 , 3 , * and Shiying Xuan 1 , 2 , 3 , *
Authors Information
1 Medical College, Qingdao University, Qingdao, China
2 Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, China
3 Digestive Disease Key Laboratory of Qingdao, Qingdao, China
4 Central Laboratories, Qingdao Municipal Hospital, Qingdao, China
5 Hepatology and Transplant Medicine, Department of Medicine, Houston Methodist Hospital, Houston, USA
Corresponding Authors:
Article information
  • Hepatitis Monthly: August 2016, 16 (8); e38558
  • Published Online: July 23, 2016
  • Article Type: Review Article
  • Received: April 17, 2016
  • Revised: June 22, 2016
  • Accepted: June 28, 2016
  • DOI: 10.5812/hepatmon.38558

To Cite: Zhang Y, Lu L, Victor D W, Xin Y, Xuan S. et al. Ursodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysis, Hepat Mon. 2016 ;16(8):e38558. doi: 10.5812/hepatmon.38558.

Abstract
Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Context
2. Evidence Acquisition
3. Results
4. Conclusions
Footnotes
References
  • 1. Kondrackiene J, Kupcinskas L. Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems. World J Gastroenterol. 2008; 14(38): 5781-8[PubMed]
  • 2. Arrese M, Reyes H. Intrahepatic cholestasis of pregnancy: a past and present riddle. Ann Hepatol. 2006; 5(3): 202-5[PubMed]
  • 3. Lee NM, Brady CW. Liver disease in pregnancy. World J Gastroenterol. 2009; 15(8): 897-906[PubMed]
  • 4. Ahmed KT, Almashhrawi AA, Rahman RN, Hammoud GM, Ibdah JA. Liver diseases in pregnancy: diseases unique to pregnancy. World J Gastroenterol. 2013; 19(43): 7639-46[DOI][PubMed]
  • 5. Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2014; 124(1): 120-33[DOI][PubMed]
  • 6. Gabzdyl EM, Schlaeger JM. Intrahepatic cholestasis of pregnancy: a critical clinical review. J Perinat Neonatal Nurs. 2015; 29(1): 41-50[DOI][PubMed]
  • 7. Diken Z, Usta IM, Nassar AH. A clinical approach to intrahepatic cholestasis of pregnancy. Am J Perinatol. 2014; 31(1): 1-8[DOI][PubMed]
  • 8. Tan LK. Obstetric cholestasis: current opinions and management. Ann Acad Med Singapore. 2003; 32(3): 294-8[PubMed]
  • 9. Pathak B, Sheibani L, Lee RH. Cholestasis of pregnancy. Obstet Gynecol Clin North Am. 2010; 37(2): 269-82[DOI][PubMed]
  • 10. Ozkan S, Ceylan Y, Ozkan OV, Yildirim S. Review of a challenging clinical issue: Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2015; 21(23): 7134-41[DOI][PubMed]
  • 11. Palma J, Reyes H, Ribalta J, Hernandez I, Sandoval L, Almuna R, et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol. 1997; 27(6): 1022-8[PubMed]
  • 12. Liu Y, Qiao F, Liu H, Liu D. Ursodeoxycholic acid in the treatment of intraheptic cholestasis of pregnancy. J Huazhong Univ Sci Technolog Med Sci. 2006; 26(3): 350-2[PubMed]
  • 13. Zapata R, Sandoval L, Palma J, Hernandez I, Ribalta J, Reyes H, et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience. Liver Int. 2005; 25(3): 548-54[DOI][PubMed]
  • 14. Glantz A, Marschall HU, Lammert F, Mattsson LA. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology. 2005; 42(6): 1399-405[DOI][PubMed]
  • 15. Kondrackiene J, Beuers U, Kupcinskas L. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology. 2005; 129(3): 894-901[DOI][PubMed]
  • 16. Frezza M, Centini G, Cammareri G, Le Grazie C, Di Padova C. S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial. Hepatogastroenterology. 1990; 37 Suppl 2: 122-5[PubMed]
  • 17. Nicastri PL, Diaferia A, Tartagni M, Loizzi P, Fanelli M. A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol. 1998; 105(11): 1205-7[PubMed]
  • 18. Binder T, Salaj P, Zima T, Vitek L. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med. 2006; 34(5): 383-91[DOI][PubMed]
  • 19. Zhang L, Liu XH, Qi HB, Li Z, Fu XD, Chen L, et al. Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial. Eur Rev Med Pharmacol Sci. 2015; 19(19): 3770-6[PubMed]
  • 20. Zhou F, Gao B, Wang X, Li J. Meta-analysis of ursodeoxycholic acid and S-adenosylmethionine for improving the outcomes of intrahepatic cholestasis of pregnancy [in Chinese]. Zhonghua Gan Zang Bing Za Zhi. 2014; 22(4): 299-304[DOI][PubMed]
  • 21. Kenyon AP, Girling JC. Obstetrics Cholestasis. 2011;
  • 22. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996; 17(1): 1-12[PubMed]
  • 23. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Ann Intern Med. 2001; 135(11): 982-9[PubMed]
  • 24. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet. 1998; 352(9128): 609-13[DOI][PubMed]
  • 25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3): 177-88[PubMed]
  • 26. Shadish WR, Haddock CK. Combining estimates of effects size. In: Cooper H, Hedges LV,ed. The handbook of research synthesis. 1994; : 261-81
  • 27. Floreani A, Paternoster D, Melis A, Grella PV. S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial. Eur J Obstet Gynecol Reprod Biol. 1996; 67(2): 109-13[PubMed]
  • 28. Roncaglia N, Locatelli A, Arreghini A, Assi F, Cameroni I, Pezzullo JC, et al. A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis. BJOG. 2004; 111(1): 17-21[PubMed]
  • 29. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009; 51(2): 237-67[DOI][PubMed]
  • 30. Azzaroli F, Turco L, Lisotti A, Calvanese C, Mazzella G. The pharmacological management of intrahepatic cholestasis of pregnancy. Curr Clin Pharmacol. 2011; 6(1): 12-7[PubMed]
  • 31. Beuers U. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol. 2006; 3(6): 318-28[DOI][PubMed]
  • 32. Almasio P, Bortolini M, Pagliaro L, Coltorti M. Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis. Drugs. 1990; 40 Suppl 3: 111-23[PubMed]
  • 33. Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol. 2000; 33(6): 1012-21[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader